Macular function surveillance revisited

Optometry

Volumn 79, Issue 7, 2008, Pages 397-403

  Trevino, Richard ^a   Kynn, Michael G ^b  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b NONE

Author keywords

Age related macular degeneration; Amsler grid; Choroidal neovascularization; Entoptic perimetry; Noise field campimetry; Preferential hyperacuity perimetry

Indexed keywords

ARTICLE; HUMAN; INSTRUMENTATION; PATHOPHYSIOLOGY; PERIMETRY; PHYSIOLOGY; RETINA DISEASE; RETINA MACULA LUTEA;

HUMANS; MACULA LUTEA; PERIMETRY; RETINAL DISEASES;

EID: 48749087117     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.optm.2007.09.017     Document Type: Article

References (50)

1. Gonzales C.R., and VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group. Enhanced efficacy associated with early treatment of neovascular age-related macular degeneration with pegaptanib sodium: an exploratory analysis. Retina 25 (2005) 815-827
2. Boyer D.S., Antoszyk A.N., Awh C.C., et al., MARINA Study Group. Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 114 (2007) 246-252
3. Macular Photocoagulation Study Group. Argon laser photocoagulation for senile macular degeneration: results of a randomized clinical trial. Arch Ophthalmol 100 (1982) 912-918
4. Macular Photocoagulation Study Group. Argon laser photocoagulation for ocular histoplasmosis: results of a randomized clinical trial. Arch Ophthalmol 101 (1983) 1347-1357
5. Macular Photocoagulation Study Group. Argon laser photocoagulation for idiopathic neovascularization: results of a randomized clinical trial. Arch Ophthalmol 101 (1983) 1358-1361
6. Blinder K.J., Bradley S., Bressler N.M., et al. Treatment of Age-related Macular Degeneration with Photodynamic Therapy Study Group, Verteporfin in Photodynamic Therapy Study Group. Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report No. 1. Am J Ophthalmol 136 (2003) 407-418
7. Fine S.L. Further thoughts on the diagnosis and treatment of patients with macular degeneration. Arch Ophthalmol 101 (1983) 1189-1190
8. Fine S.L., and Macular Photocoagulation Study Group. Early detection of extrafoveal neovascular membranes by daily central field evaluation. Ophthalmology 92 (1985) 603-609
9. Fine A.M., Elman M.J., Ebert J.E., et al. Earliest symptoms caused by neovascular membranes in the macula. Arch Ophthalmol 104 (1986) 513-514
10. Marmor M.F. A brief history of macular grids: from Thomas Reis to Edvard Munch and Marc Amsler. Surv Ophthalmol 44 (2000) 343-353
11. Amsler M. Earliest symptoms of diseases of the macula. Br J Ophthalmol 37 (1953) 521-537
12. Schlaegel Jr. T.F., Cofield D.D., Clark G., et al. Photocoagulation and other therapy for histoplasmic choroiditis. Trans Am Acad Ophthalmol Otolaryngol 72 (1968) 355-363
13. Wolfe K.A., and Sadun A.A. Threshold Amsler grid testing in diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 229 (1991) 219-223
14. Teich S.A., and Saltzman B.R. Evaluation of a new self-screening chart for cytomegalovirus retinitis in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 13 (1996) 336-342
15. Schuchard R.A. Validity and interpretation of Amsler grid reports. Arch Ophthalmol 111 (1993) 776-780
16. Zaidi F.H., Cheong-Leen R., Gair E.J., et al. The Amsler chart is of doubtful value in retinal screening for early laser therapy of subretinal membranes. The West London Survey. Eye 18 (2004) 503-508
17. Sunness J.S., Schuchard R.A., Shen N., et al. Landmark-driven fundus perimetry using the scanning laser ophthalmoscope. Invest Ophthalmol Vis Sci 36 (1995) 1863-1874
18. Crossland M., and Rubin G. The Amsler chart: absence of evidence is not evidence of absence. Br J Ophthalmol 91 (2007) 391-393
19. Amsler M. L'examen qualitatif de la fonction maculaire. Ophthalmologica 114 (1947) 248-261
20. Agustin A.J., Offermann I., Lutz J., et al. Comparison of the original Amsler grid with the modified Amsler grid: Result for patients with age-related macular degeneration. Retina 25 (2005) 443-445
21. Achard O.A., Safran A.B., Duret F.C., et al. Role of the completion phenomenon in the evaluation of Amsler grid results. Am J Ophthalmol 120 (1995) 322-329
22. American Academy of Ophthalmology. Preferred practice pattern: age-related macular degeneration. Limited revision (2005), American Academy of Ophthalmology, San Francisco, CA
23. Easterbrook M. The sensitivity of Amsler grid testing in early chloroquine retinopathy. Trans Ophthalmol Soc UK 104 (1985) 204-207
24. Almony A., Garg S., Peters R.K., et al. Threshold Amsler grid as a screening tool for asymptomatic patients on hydroxychloroquine therapy. Br J Ophthalmol 89 (2005) 569-574
25. Pluenneke A.C., and Blomquist P.H. Utility of red Amsler grid screening in a rheumatology clinic. J Rheumatol 31 (2004) 1754-1755
26. Wall M., and Sadun A.A. Threshold Amsler grid testing. Cross-polarizing lenses enhance yield. Arch Ophthalmol 104 (1986) 520-523
27. Cheng A.S., and Vingrys A.J. Visual losses in early age-related maculopathy. Optom Vis Sci 70 (1993) 89-96
28. Fink W., and Sadun A.A. Three-dimensional computer-automated threshold Amsler grid test. J Biomed Opt 9 (2004) 149-153
29. Nazemi P.P., Fink W., Lim J.I., et al. Scotomas of age-related macular degeneration detected and characterized by means of a novel three-dimensional computer-automated visual field test. Retina 25 (2005) 446-453
30. Aulhorn E., and Köst G. Rauschfeldkampimetrie: eine perimetrische Untersuchungsweise. Klin Monatsbl Augenheilkd 192 (1988) 284-288
31. Plummer D.J., Azen S.P., and Freeman W.R. Scanning laser entoptic perimetry for the screening of macular and peripheral retinal disease. Arch Ophthalmol 118 (2000) 1205-1210
32. Shirato S., Adachi M., and Hara T. Subjective detection of visual field defects using home TV set. Jpn J Ophthalmol 35 (1991) 273-281
33. Freeman W.R., El-Brady M., and Plummer D.J. Scanning laser entoptic perimetry for the detection of age-related macular degeneration. Arch Ophthalmol 122 (2004) 1647-1651
34. El-Bradey M., Plummer D.J., Uwe-Bartsch D., et al. Scanning laser entoptic perimetry for the detection of visual defects associated with diabetic retinopathy. Br J Ophthalmol 90 (2006) 17-19
35. Brown J.C., Kylstra J.A., and Mah M.L. Entoptic perimetry screening for central diabetic scotomas and macular edema. Ophthalmology 107 (2000) 755-759
36. Plummer D.J., Banker A., Taskintuna I., et al. The utility of entoptic perimetry as a screening test for cytomegalovirus retinitis. Arch Ophthalmol 117 (1999) 202-207
37. Schiefer U., Gisolf A.C., Kirsch J., et al. Rauschfeld-Screening Ergebnisse einer Fernsehfeldstudie zur Detektion von Gesichtsfelddefekten. Ophthalmologe 93 (1996) 604-616
38. Levi D.M., Klein S.A., and Carney T. Unmasking the mechanisms for Vernier acuity: evidence for a template model for Vernier acuity. Vision Res 40 (2000) 951-972
39. Goldstein M., Loewenstein A., Barak A., et al., Preferential Hyperacuity Perimeter Research Group. Results of a multicenter clinical trial to evaluate the preferential hyperacuity perimeter for detection of age-related macular degeneration. Retina 25 (2005) 296-303
40. Alster Y., Bressler N.M., Bressler S.B., et al., Preferential Hyperacuity Perimetry Research Group. Preferential hyperacuity perimeter (PreView PHP) for detecting choroidal neovascularization study. Ophthalmology 112 (2005) 1758-1765
41. Loewenstein A., Malach R., Goldstein M., et al. Replacing the Amsler grid: a new method for monitoring patients with age-related macular degeneration. Ophthalmology 110 (2003) 966-970
42. Loewenstein A. The significance of early detection of age-related macular degeneration. Retina 27 (2007) 873-878
43. Kampmeier J., Zorn M.M., Lang G.K., et al. Vergleich des Preferential-Hyperacuity-Perimeter (PHP)-tests mit dem Amsler-netz-test bei der diagnose verschiedener stadien der altersbezogenen makuladegeneration. Klin Monatsbl Augenheilkd 223 (2006) 752-756
44. Klatt C., Sendtner P., Ponomareva L., et al. Diagnostik von metamorphopsien bei netzhauterkrankungen unterschiedlicher genese. Ophthalmologe 103 (2006) 945-952
45. Kuchenbecker J., and Lindner H. Visual function tests on the Internet-sense or nonsense?. Strabismus 12 (2004) 97-102
46. MyVisionTest vision testing module. http://www.myvisiontest.com Last accessed December 2, 2007
47. Peristat Group, Incorporated. Macustat vision testing module. http://www.keepyoursight.com Last accessed December 2, 2007
48. Eysenbach G. What is e-health?. J Med Internet Res [serial on the Internet] 3 (2001) e20. http://www.jmir.org/2001/2/e20/ Available at: http://www.jmir.org/2001/2/e20/. Last accessed June 12, 2006
49. Wantland D.J., Portillo C.J., Holzemer W.L., et al. The effectiveness of Web-based vs. non-Web-based interventions: a meta-analysis of behavioral change outcomes. J Med Internet Res [serial on the Internet]. 6 (2004) e40. http://www.jmir.org/2004/4/e40/ Available at: http://www.jmir.org/2004/4/e40/. Last accessed June 12, 2006
50. Fox S. Older Americans and the Internet [document on the Internet] (2004), Pew Internet & American Life Project, Washington DC. http://www.pewinternet.org/report_display.asp?r=117 Mar 25. Available at: http://www.pewinternet.org/report_display.asp?r=117. Last accessed June 15, 2006